The pharmacological profile of viloxazine shows promise for improving executive dysfunction in adults based on its demonstrated efficacy in children, making it worth trying for this purpose clinically despite the lack of direct adult-based evidence.
normativepending
Speaker
Dr. Tracey MarksEvidence Quote
“But the fact that the profile of the drug shows that it improves executive dysfunction in children is promising and worth trying to use it for this purpose in adults.”
Created: 8/11/2026, 7:48:09 AM
Your notes
Loading notes...